Lineage Cell Therapeutics Inc (XTAE:LCTX)
₪ 3.294 0.074 (2.3%) Market Cap: 632.94 Mil Enterprise Value: 497.81 Mil PE Ratio: 0 PB Ratio: 2.44 GF Score: 62/100

Q4 2022 Lineage Cell Therapeutics Inc Earnings Call Transcript

Mar 09, 2023 / 09:30PM GMT
Release Date Price: ₪5.18 (+2.55%)
Operator

Welcome to the Lineage Cell Therapeutics Fourth Quarter and Full Year 2022 Conference Call. At this time, all participants are in a listen only mode. An audio webcast of this call is available on the Investors section of Lineage's website at www.lineagecell.com.

This call is subject to copyright and is property of Lineage. And recordings, reproductions or transmission of this call without the express written consent of Lineage are strictly prohibited. As a reminder, today's call is being recorded.

I would now like to introduce to you your host for today's call, Ioana Hone, Head of Investor Relations at Lineage. Ms. Hone, please go ahead.

Ioana C. Hone
Lineage Cell Therapeutics, Inc. - Senior Director of IR

Thanks, Mandeep. Good afternoon, and thank you for joining us.

A press release reporting our fourth quarter and full year 2022 financial results was issued earlier today, March 9, 2023, and can be found on the Investors section of our website.

Please

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot